Minerva Neurosciences (NERV) Invested Capital (2013 - 2018)
Minerva Neurosciences (NERV) reported Invested Capital of $112.06 million for Q2 2018, up 7.3% from $104.43 million a year earlier but down 9.6% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Invested Capital (2013 - 2018) Analysis & Trends
For FY2017, Minerva Neurosciences posted Invested Capital of $135.56 million, up 18.2% from FY2016.
- Invested Capital has a four-year compound annual growth rate of 60.9% (FY2013 to FY2017).
- By year, Invested Capital came in at $114.68 million in FY2016 (+75.7%), $65.26 million in FY2015 and $20.24 million in FY2013.
- Five-year quarterly Invested Capital spans a low of $20.24 million in Q4 2013 and a high of $135.56 million in Q4 2017.
- Year over year, Invested Capital has now increased in each of the last four quarters, with growth averaging 27.2% over the last eight quarters.
- The high point for year-over-year Invested Capital in five years was Q2 2015 (growth of 139.6%); the low point was Q2 2017 (a decline of 20.1%).
- Per Business Quant data, the three quarters before Q2 2018 came in at $123.99 million (Q1 2018), $135.56 million (Q4 2017) and $135.37 million (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Minerva Neurosciences | 158.21 Mn | 158.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 112.06 Mn |
| Mar 31, 2018 | 123.99 Mn |
| Dec 31, 2017 | 135.56 Mn |
| Sep 30, 2017 | 135.37 Mn |
| Jun 30, 2017 | 104.43 Mn |
| Mar 31, 2017 | 113.85 Mn |
| Dec 31, 2016 | 114.68 Mn |
| Sep 30, 2016 | 122.94 Mn |
| Jun 30, 2016 | 130.71 Mn |
| Mar 31, 2016 | 76.67 Mn |
| Dec 31, 2015 | 65.26 Mn |
| Sep 30, 2015 | 72.92 Mn |
| Jun 30, 2015 | 78.16 Mn |
| Mar 31, 2015 | 84.14 Mn |
| Jun 30, 2014 | 32.62 Mn |
| Dec 31, 2013 | 20.24 Mn |
API Access
Minerva Neurosciences Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();